Vandeputte, C., Guizon, I., Genestie-Denis, I., Vannier, B
A drug approved by the FDA in January 2025 might not be reimbursed in France until late 2026
Preparing for Your Procedure Once youve decided to move forward, well help you prepare every step of the way
Common experience points include: Early weeks may bring reduced appetite and earlier fullness Some people notice less interest in heavy or greasy foods Weight loss often becomes clearer after dose increases and consistent routines Hydration and protein help reduce fatigue and support lean mass Strength training supports metabolism and improves body composition Weekly injections are usually simple and quick
Further studies on RGC in relation to the time of the last dose of GLP-1 agonists also have varying results, making set timeframes to stop the use of GLP-1 s preoperatively difficult to determine (Santos et al